Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings

<p>Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment of $2.15 per Share and a Contingent Value Right of $0.85 per Share on Achievement of a Commercial Milestone for a Total Potential Value of $3.00 per Share Special Meeting of Stockholders to be Held on Sept. 18, 2023 at […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/paratek-pharmaceuticals-files-definitive-proxy-statement-and-letter-to-stockholders-in-connection-with-acquisition-by-gurnet-point-capital-and-novo-holdings/">Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>